Identification of Altered Transcripts and Pathways in Triple Negative Breast Cancer
, , , , , y
09 mar 2023
Acerca de este artículo
Publicado en línea: 09 mar 2023
Páginas: 33 - 40
Recibido: 15 dic 2021
Aceptado: 11 ago 2022
DOI: https://doi.org/10.2478/prolas-2023-0004
Palabras clave
© 2023 Elza Kuzņecova et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Kuzņecova, Elza
Institute of Oncology, Rīga Stradiņš UniversityLatvia
Daneberga, Zanda
Institute of Oncology, Rīga Stradiņš UniversityLatvia
Berga-Švītiņa, Egija
Institute of Oncology, Rīga Stradiņš UniversityLatvia
Nakazawa-Miklaševiča, Miki
Institute of Oncology, Rīga Stradiņš UniversityLatvia
Irmejs, Arvīds
Institute of Oncology, Rīga Stradiņš UniversityLatvia
Breast Unit, Pauls Stradiņš Clinical University HospitalLatvia
Gardovskis, Jānis
Institute of Oncology, Rīga Stradiņš UniversityLatvia
Department of Surgery, Rīga Stradiņš UniversityLatvia
Department of Surgery, Pauls Stradiņš Clinical University HospitalLatvia
Miklaševičs, Edvīns
Institute of Oncology, Rīga Stradiņš UniversityLatvia